BGI Genomics (300676.SZ) Earnings Analysis

BGI Genomics (300676.SZ) has no confirmed upcoming earnings date. Trailing P/E -26.73.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300676.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300676.SZ. This page updates as the calendar is published.

300676.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-25-1.43 CNYn/an/an/a
2025-10-23-0.06525 CNYn/an/an/a
2025-04-25-1.88802 CNYn/an/an/a
2025-03-31-0.1278 CNYn/an/an/a
2024-10-25-0.34524 CNYn/an/an/a
2024-08-230.0139 CNYn/an/an/a

300676.SZ valuation and analyst view

Trailing P/E-26.73
Trailing EPS-1.37941 CNY
Price / book1.82
Dividend yield0.00%
Market cap15.68B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is BGI Genomics (300676.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300676.SZ. This page updates as the calendar is published.

Did 300676.SZ beat earnings last quarter?

Consensus estimate data was not available for 300676.SZ's 2026-04-25 report.

What is 300676.SZ's current P/E ratio and EPS?

300676.SZ trades at a trailing P/E of -26.73 on trailing EPS of -1.3794106884474737 CNY.

What do analysts rate 300676.SZ?

300676.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.